The role involves leading end-to-end translational safety strategies for gene-modified CAR T cell products across early- and late-stage clinical programs
Job Summary
The role involves leading end-to-end translational safety strategies for gene-modified CAR T cell products across early- and late-stage clinical programs.
Candidates must possess deep expertise in immunology, molecular/cell biology, or virology to drive scientific rigor in complex case investigations.
Bristol Myers Squibb offers a wide variety of competitive benefits including health coverage, financial protection, and flexible work-life balance options.
Matching Summary
The role involves leading end-to-end translational safety strategies for gene-modified CAR T cell products across early- and late-stage clinical programs.
Salary
Base: $152,360 - $184,628; Bonus/Equity: Additional incentive cash and stock opportunities available; Benefits: Health coverage, 401(k), paid time off, and wellbeing support